- 20 May, 2024
Nvidia eyes $280 after consolidating at $200. Consider adding stock
Nvidia Corporation (NASDAQ:NVDA) has maintained price levels above the $200 support level. This week, the stock’s lowest price was $212, with the highest at $227.
Bed Bath and Beyond stock slides 15% on Q4 results
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Where to buy Vertical Aerospace stock: it has surged to a 3-month high on volume surge
Vertical Aerospace stock, the Shares of London-based zero-emission electric airplanes start-up Vertical Aerospace, surged by about 42% on Tuesday and continued on the same trajectory
Dell Technologies is a great value investment candidate. The price target is $60
Dell Technologies Inc. (NYSE:DELL) is a stock to watch in the computer hardware industry. Last week, it emerged that Dell’s peer in the industry, HP
Inflation is a massive problem that can no longer be hidden
Yesterday, the White House came out with the below video, warning the public that the inflation readings were going to be “extraordinarily elevatedâ€. That in
Datto is up 20% after announcing the Kaseya acquisition agreement
Datto (NYSE: MSP), a top provider of cloud-based and security software options for MSPs, and Kaseya, a leading provider of security and IT management software for
Tilray Brands and Hexo sign definitive commercial and financial partnership agreement
Tilray Brands Inc. (NASDAQ: TLRY) has announced a financial and commercial partnership definitive agreement with Hexo Corp (NASDAQ: HEXO). This strategic partnership creates a collaboration
Ambev S.A is set to rally. Buy now to lock in value before the price rally
Ambev S.A (BSP:ABEV3) closed the last trading session at $3.24. The 52-week range has been between 2.50 and $3.95. The expected growth rate is at
AMD at $97 is trading below fair value. Should we expect gains?
Advanced Micro Devices, Inc. (NASDAQ:AMD) closed the last trading session at $97.37. The daily range was between $96 and $101. A notable concern is that
Bicycle Therapeutics reports promising BT8009 study results, shares tank 30%
Bicycle Therapeutics plc (NASDAQ: BCYC) is down 30% after the biotech firm pioneering novel and differentiated therapeutics class based on its bicyclin peptide tech announced